article thumbnail

STAT+: Which hospital systems will join Kaiser’s Risant next?

STAT

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry. Nothing has happened since then, at least publicly.

Hospitals 317
article thumbnail

STAT+: Amid divorce from Dana-Farber, Mass General Brigham touts its own cancer institute

STAT

More than a year has passed since Dana-Farber Cancer Institute  dumped Mass General Brigham for a rival hospital chain , but the state’s biggest health care system is making a push now to say when it comes to cancer care, MGB’s still got it. billion cancer hospital in the Longwood Medical Area.

Hospitals 249
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Brigham and Women’s exec opens up about the Dana-Farber Cancer Institute split, and what it means for the future of cancer care

STAT

Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration.

Hospitals 341
article thumbnail

Pfizer India, State of Goa launch ‘Project Parivartan’ to tackle AMR

Express Pharma

Pfizer India, in collaboration with the Government of Goa, Goa Medical College and Hospital (GMC), Directorate of Health Services (DHS), and Americares India Foundation, launched Project Parivartan. A 2021 ICMR study reported AMR-related fatality rates of 38.1 per cent in bloodstream infections and 27.9

Hospitals 105
article thumbnail

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

pharmaphorum

According to Novartis, Kesimpta is the first targeted B cell therapy for RMS that can be self-administered at home once a month using an autoinjector, avoiding the need for patients to travel to hospital during the pandemic, and easing the pressure on clinicians. billion by 2028. billion in sales in 2028.

Hospitals 111
article thumbnail

Smartphone-based skin cancer diagnostic certified for use in UK

pharmaphorum

Last September, a report by the Institute for Public Policy Research (IPPR) and Carnall Farrar (CF) consultancy suggested it could take until 2033 to clear the backlog unless hospitals can raise their operating capacity significantly.

Hospitals 145
article thumbnail

Happitech launches smartphone app for cardiac researchers

pharmaphorum

FastStart Research has been developed with the help of partners at Mount Sinai and Boston Children’s Hospital in the US, and the OLVG hospital group, Vrije Universiteit Amsterdam, the Dutch Heart Foundation (Hartstichting), and UMC Utrecht in the Netherlands.

Hospitals 104